We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
GE Healthcare Launches New Cell Culture Solution Product; Xuri™ MSC Medium
Product News

GE Healthcare Launches New Cell Culture Solution Product; Xuri™ MSC Medium

GE Healthcare Launches New Cell Culture Solution Product; Xuri™ MSC Medium
Product News

GE Healthcare Launches New Cell Culture Solution Product; Xuri™ MSC Medium


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "GE Healthcare Launches New Cell Culture Solution Product; Xuri™ MSC Medium "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Xuri™ MSC Medium is a versatile and reliable cell culture product that enables the safe and efficient expansion of human mesenchymal stem cells (hMSC) without the use of animal derived components or undefined serum. It can be used to culture hMSC from a range of sources, including bone marrow, umbilical cord, or adipose tissue.

Compared to serum-facilitated cultivation, Xuri MSC Medium achieves a higher yield of multipotent cells in a single passage, thereby reaching the desired cell dose for patient treatment in a shorter timescale. Removing the need for lengthy batch validation and risk assessment associated with serum also enables a faster and more cost effective process.

Xeno-Free Xuri MSC Attachment Solution is the recommended coating agent for the serum-free expansion of hMSC with Xuri MSC Medium and supports high reproducibility across batches.
Xuri products are supplied with a comprehensive documentation support package that follows USP <1043> requirements applicable to a supplier on ancillary material for cell, gene and tissue-engineered products. All human components included in the product undergo extensive testing in accordance with regulatory requirements.

Advertisement